AAAAAA

   
Results: 1-2 |
Results: 2
Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8
Authors: Norris, B Pritchard, KI James, K Myles, J Bennett, K Marlin, S Skillings, J Findlay, B Vandenberg, T Goss, P Latreille, J Rudinskas, L Lofters, W Trudeau, M Osoba, D Rodgers, A
Citation: B. Norris et al., Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8, J CL ONCOL, 18(12), 2000, pp. 2385-2394
Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine. HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study
Authors: Khoo, K Brandes, L Reyno, L Arnold, A Dent, S Vandenberg, T Lebwohl, D Fisher, B Eisenhauer, E
Citation: K. Khoo et al., Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine. HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study, J CL ONCOL, 17(11), 1999, pp. 3431-3437
Risultati: 1-2 |